Tan H, Liu Y, Zhu G, Pi L, Huang D, Zhang X. An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma.
Onco Targets Ther 2014;
7:1535-40. [PMID:
25214794 PMCID:
PMC4159496 DOI:
10.2147/ott.s66145]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Objective
To investigate the pathology and pathogenesis of and treatment methods for temporal bone verrucous carcinoma.
Materials and methods
A single-patient report of verrucous carcinoma on the left external auditory canal is presented and analyzed along with all cases of temporal bone verrucous carcinoma that have been documented in the English literature.
Results
Most of the patients with verrucous carcinoma of the temporal bone have histories of surgery, trauma, or infection, and verrucous carcinomas are sensitive to antimicrotubule chemotherapeutic medicines. Adjuvant radiation therapy is not effective, but surgical treatment might be relatively more effective.
Conclusion
Temporal bone verrucous carcinoma has a poor prognosis; therefore, the preferred treatment is surgical resection facilitated with antimicrotubule chemotherapeutic treatment. Adjuvant radiation therapy is not a preferred treatment for temporal bone verrucous carcinoma.
Collapse